Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000315066-26-002829·Royalty Pharma plc
Schedule 13G ownership disclosure
ROYALTY PHARMA PLC- CL A
CLASS A COMMON STOCK · CUSIP: G7709Q104
Event date: 2026-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- FMR LLC
Shares: 19,288,880.43 · Class: 4.3%
- Abigail P. Johnson
Shares: 19,288,880.43 · Class: 4.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000315066-26-002829
- Form type
- SCHEDULE 13G/A
- Filer
- Royalty Pharma plc
- CIK
- CIK 1802768
- Filed
- Nov 05, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership